Fixed-dose darunavir/cobicistat in pregnancy of HIV-infected women, pharmacokinetic concerns

被引：2

作者：

Dash, Prasanta K. ^{[1
]}

Boix, Vicente ^{[2
,3
]}

机构：

[1] Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA

[2] Hosp Gen Univ Alicante, ISABIAL, Unit Infect Dis, Alicante, Spain

[3] Univ Miguel Hernandez, Dept Med Clin, Elche, Spain

来源：

AIDS | 2021年 / 35卷 / 08期

关键词：

IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEASE; PHARMACODYNAMICS; COBICISTAT; DARUNAVIR; GS-9350;

D O I：

10.1097/QAD.0000000000002886

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1301 / 1303

页数：3

共 50 条

[21] Abacavir/Lamivudine Fixed-Dose Combination With Ritonavir-Boosted Darunavir: A Safe and Efficacious Regimen for HIV Therapy [J].

Trottier, Benoit ;

Machouf, Nima ;

Thomas, Rejean ;

Gallant, Serge ;

Longpre, Daniele ;

Vezina, Sylvie ;

Boissonnault, Michel ;

Lavoie, Stephane ;

Legault, Danielle ;

Dion, Harold ;

Vinh Kim Nguyen .

HIV CLINICAL TRIALS, 2012, 13 (06) :335-342

[22] Pediatric darunavir/cobicistat fixed-dose combination tablet for dispersion: Bioequivalence versus separate agents in healthy participants and acceptability in children living with human immunodeficiency virus-1 [J].

Van Hemelryck, Sandy ;

Van Landuyt, Erika ;

Deleu, Sofie ;

Leopold, Lorant ;

Ariyawansa, Jay ;

Palmer, Martyn ;

Labourdette, Maria .

ANTIVIRAL THERAPY, 2025, 30 (03) :13596535251349336

[23] Pharmacokinetic Interactions Between the Fixed-Dose Combinations of Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine and Elbasvir/Grazoprevir in Healthy Adult Participants [J].

Feng, Hwa-Ping ;

Guo, Zifang ;

Fandozzi, Christine ;

Panebianco, Deborah ;

Caro, Luzelena ;

Wolford, Dennis ;

Dreyer, Daniel R. ;

Valesky, Robert ;

Martinho, Monika ;

Rizk, Matthew L. ;

Iwamoto, Marian ;

Yeh, Wendy W. .

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (07) :952-961

[24] Etravirine Pharmacokinetics in HIV-Infected Pregnant Women [J].

Mulligan, Nikki ;

Schalkwijk, Stein ;

Best, Brookie M. ;

Colbers, Angela ;

Wang, Jiajia ;

Capparelli, Edmund V. ;

Molto, Jose ;

Stek, Alice M. ;

Taylor, Graham ;

Smith, Elizabeth ;

Tenorio, Carmen Hidalgo ;

Chakhtoura, Nahida ;

van Kasteren, Marjo ;

Fletcher, Courtney V. ;

Mirochnick, Mark ;

Burger, David .

FRONTIERS IN PHARMACOLOGY, 2016, 7

[25] Pharmacokinetic interaction between nevirapine and darunavir with low-dose ritonavir in HIV-1-infected patients [J].

Sekar, Vanitha ;

Lefebvre, Eric ;

Marien, Kris ;

De Pauw, Martine ;

Vangeneugden, Tony ;

Pozniak, Anton ;

Hoetelmans, Richard M. W. .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (01) :116-119

[26] HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study [J].

Harris, Marianne ;

Ganase, Bruce ;

Watson, Birgit ;

Harrigan, P. Richard ;

Montaner, Julio S. G. ;

Hull, Mark W. .

AIDS RESEARCH AND THERAPY, 2017, 14 :1-9

[27] Pharmacokinetic interaction between single and multiple doses of darunavir, in combination with cobicistat or ritonavir, and single-dose dabigatran etexilate in healthy adults [J].

Sandy Van Hemelryck ;

Erika Van Landuyt ;

Jay Ariyawansa ;

Martyn Palmer ;

Martine J. C. Kothe ;

Caroline Pollefliet .

AAPS Open, 10 (1)

[28] HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study [J].

Marianne Harris ;

Bruce Ganase ;

Birgit Watson ;

P. Richard Harrigan ;

Julio S. G. Montaner ;

Mark W. Hull .

AIDS Research and Therapy, 14

[29] Darunavir, promising option in therapy multi-experience HIV-infected patients [J].

Olczak, Anita .

HIV & AIDS REVIEW, 2008, 7 (01) :5-9

[30] Influence of darunavir coadministration on nevirapine pharmacokinetics in HIV-infected patients: a population approach [J].

Dailly, E. ;

Raffi, F. ;

Perre, P. ;

Martin, J. ;

Deslandes, G. ;

Jolliet, P. .

HIV MEDICINE, 2009, 10 (09) :586-589

← 1 2 3 4 5 →